Mirae Asset Global Investments Co., Ltd. Glaukos Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$76.4 - $96.33 $85,338 - $107,600	-1,117 Reduced 4.55%	23,425 $2.21 Million
Q4 2023 Jan 24, 2024	BUY	$59.53 - $85.11 $36,313 - $51,917	610 Added 2.55%	24,542 $1.95 Million
Q3 2023 Oct 26, 2023	BUY	$69.23 - $79.09 $84,599 - $96,647	1,222 Added 5.38%	23,932 $1.8 Million
Q2 2023 Aug 10, 2023	SELL	$45.44 - $71.21 $32,489 - $50,915	-715 Reduced 3.05%	22,710 $1.62 Million
Q1 2023 May 04, 2023	BUY	$43.88 - $52.48 $64,284 - $76,883	1,465 Added 6.67%	23,425 $1.17 Million
Q4 2022 Feb 09, 2023	BUY	$40.82 - $57.75 $16,042 - $22,695	393 Added 1.82%	21,960 $959,000
Q3 2022 Nov 10, 2022	BUY	$46.84 - $58.49 $243,333 - $303,855	5,195 Added 31.73%	21,567 $1.15 Million
Q2 2022 Jul 26, 2022	BUY	$34.86 - $63.77 $570,727 - $1.04 Million	16,372 New	16,372 $744,000
Q2 2021 Aug 11, 2021	SELL	$73.06 - $97.7 $206,613 - $276,295	-2,828 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$70.43 - $97.42 $55,217 - $76,377	-784 Reduced 21.71%	2,828 $237,000
Q4 2020 Feb 10, 2021	BUY	$48.9 - $75.26 $176,626 - $271,839	3,612 New	3,612 $272,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.